Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification.
Genome editing by Cas9, which cleaves double-stranded DNA at a sequence programmed by a short single-guide RNA (sgRNA), can result in off-target DNA modification that may be detrimental in some applications. To improve DNA cleavage specificity, we generated fusions of catalytically inactive Cas9 and FokI nuclease (fCas9). DNA cleavage by fCas9 requires association of two fCas9 monomers that simultaneously bind target sites ∼15 or 25 base pairs apart. In human cells, fCas9 modified target DNA sites with >140-fold higher specificity than wild-type Cas9 and with an efficiency similar to that of paired Cas9 'nickases', recently engineered variants that cleave only one DNA strand per monomer. The specificity of fCas9 was at least fourfold higher than that of paired nickases at loci with highly similar off-target sites. Target sites that conform to the substrate requirements of fCas9 occur on average every 34 bp in the human genome, suggesting the versatility of this approach for highly specific genome-wide editing.
Department of Chemistry & Chemical Biology, Harvard University, Cambridge, MA, USA.|Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA.
John P
JP
Guilinger
Department of Chemistry & Chemical Biology, Harvard University, Cambridge, MA, USA.|Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA.
David B
DB
Thompson
Department of Chemistry & Chemical Biology, Harvard University, Cambridge, MA, USA.|Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA.
David R
DR
Liu
D001426:Bacterial Proteins / Q000737:chemistry / Q000235:genetics*; D000076987:CRISPR-Associated Protein 9; D064113:CRISPR-Cas Systems; D064112:Clustered Regularly Interspaced Short Palindromic Repeats; D015252:Deoxyribonucleases, Type II Site-Specific / Q000737:chemistry / Q000235:genetics*; D004720:Endonucleases / Q000737:chemistry / Q000235:genetics*; D000072669:Gene Editing / Q000379:methods*; D015894:Genome, Human; D006801:Humans; D055503:Protein Multimerization; D012313:RNA / Q000235:genetics; D011993:Recombinant Fusion Proteins / Q000737:chemistry / Q000235:genetics*
D001426:Bacterial Proteins; D011993:Recombinant Fusion Proteins; D012313:RNA; D000076987:CRISPR-Associated Protein 9; C000606107:Cas9 endonuclease Streptococcus pyogenes; D004720:Endonucleases; C035042:endodeoxyribonuclease FokI; D015252:Deoxyribonucleases, Type II Site-Specific